FRED HUTCHINSON CANCER CENTER
Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission
- Conditions
- Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Acute Myelomonocytic Leukemia (M4)Adult Erythroleukemia (M6a)Adult Pure Erythroid Leukemia (M6b)Secondary Acute Myeloid LeukemiaAdult Acute Myeloblastic Leukemia Without Maturation (M1)
- Interventions
- Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationRadiation: total-body irradiationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00045435
- Locations
- 🇺🇸
OHSU Cancer Institute, Portland, Oregon, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
- Conditions
- Infection
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-05-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 184
- Registration Number
- NCT00016068
- Locations
- 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸University of Florida Shands Cancer Center, Gainesville, Florida, United States
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
- Conditions
- LymphomaUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00027937
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
- Conditions
- LeukemiaMyelodysplastic Syndromes
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-05-13
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00024050
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
- Conditions
- Cervical CancerVaginal Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00005941
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
- Conditions
- LeukemiaMyelodysplastic Syndromes
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00005853
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
- Conditions
- LymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesLeukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 390
- Registration Number
- NCT00003913
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
- Conditions
- Infection
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00016081
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Refractory Anemia With Excess BlastsRelapsing Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)B-cell Adult Acute Lymphoblastic LeukemiaChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesAdult Acute Myeloid Leukemia With t(8;21)(q22;q22)
- Interventions
- Biological: therapeutic allogeneic lymphocytesBiological: aldesleukinProcedure: peripheral blood stem cell transplantationProcedure: allogeneic bone marrow transplantationOther: laboratory biomarker analysisGenetic: gene expression analysisOther: immunologic techniqueOther: flow cytometryGenetic: polymerase chain reactionGenetic: cytogenetic analysisOther: staining method
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT00052520
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
- Conditions
- Estrogen Receptor-negative Breast CancerMale Breast CancerEstrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerInflammatory Breast CancerProgesterone Receptor-positive Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
- Interventions
- Biological: aldesleukinBiological: sargramostimProcedure: peripheral blood stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT00003199
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium, Seattle, Washington, United States